Global Opioid-Induced Constipation (OIC) Treatment Industry Production, Sales and Consumption Status and Prospects Professional Market Research Report 2017-2022

SKU ID :HNY-11031723 | Published Date: 30-May-2017 | No. of pages: 153
This report focus on Global and regional market, providing information on major players like manufacturers, suppliers, distributors, traders, customers, investors and etc., major types, major applications and etc. Data type include capacity, production, market share, price, revenue, cost, gross, gross margin, growth rate, consumption, import, export and etc. Industry chain, manufacturing process, cost structure, marketing channel are also analyzed in this report.

This report provides valuable information for companies like manufacturers, suppliers, distributors, traders, customers, investors and individuals who have interests in this industry.

Major companies are as follows:
GlaxoSmithKline; Inc.;
AstraZeneca plc; Inc.;
Pfizer; Inc.;
S.L.A. Pharma AG;
AIKO Biotechnology;
Cubist Pharmaceuticals;
Salix Pharmaceuticals; Inc.
Takeda Pharmaceutical Company Limited



Major classifications are as follows:
Naloxegol
Lubiprostone
Methylnaltrexone Bromide

Major applications are as follows:
Oral
Parenteral (Subcutaneous Injection)


Major regions are as follows:
Europe
North America
China
Japan
Southeast Asia
  • PRICE
  • $3500
    $10500
    Buy Now

Our Clients